Skip to main content
Premium Trial:

Request an Annual Quote

GSK Frees Its Data

GSK officially announced last Friday that it will make genomic profiling data for over 300 cancer cell lines free through the NCI's caBIG database, according to a post at Wired. Most of it is microarray data and comes from diseased breast, prostate, lung, and ovarian tissues. Says Richard Wooster, Director of Translational Medicine Oncology, R&D, in a press release, "…we hope this data will further drive the identification of predictive biomarkers and lead to shorter, more directed clinical trials allowing us to bring drugs more quickly to patients who need them."

The Scan

Another Resignation

According to the Wall Street Journal, a third advisory panel member has resigned following the US Food and Drug Administration's approval of an Alzheimer's disease drug.

Novavax Finds Its Vaccine Effective

Reuters reports Novavax's SARS-CoV-2 vaccine is more than 90 percent effective in preventing COVID-19.

Can't Be Used

The US Food and Drug Administration says millions of vaccine doses made at an embattled manufacturing facility cannot be used, the New York Times reports.

PLOS Papers on Frozen Shoulder GWAS, Epstein-Barr Effects on Immune Cell Epigenetics, More

In PLOS this week: genome-wide association study of frozen shoulder, epigenetic patterns of Epstein-Barr-infected B lymphocyte cells, and more.